印度 -
英文 -
Central Drugs Standard Control Organization
hydisol 100ml syr
ethilex hc. - disodium hydrogen citrate - syr - 1.53g/5ml - 100ml
印度 -
英文 -
Central Drugs Standard Control Organization
lotid 10 dt
ethilex hc. - loratadine - dt - 10mg - 10
印度 -
英文 -
Central Drugs Standard Control Organization
petzol 10 cap
ethilex hc. - omeprazole - cap - 20mg - 10
印度 -
英文 -
Central Drugs Standard Control Organization
remetuss-a 100ml syr
ethilex hc. - salbutamol,theophylline - syr - 1,50;mg;/5ml - 100ml
印度 -
英文 -
Central Drugs Standard Control Organization
remetuss-d 100ml syr
ethilex hc. - dextromethorphan hbr,triprolidine hcl.,pseudoephedrine hcl.,menthol - syr - 10,30,30,1.5;mg/5ml - 100ml
印度 -
英文 -
Central Drugs Standard Control Organization
remetuss-p 50ml/100ml liq
ethilex hc. - bromhexine hcl.,guaiphenesin,pseudoephedrine hcl. - liq - 4,50,30;mg/5ml - 50ml/100ml
新西兰 -
英文 -
Medsafe (Medicines Safety Authority)
docetaxel sandoz
novartis new zealand ltd - docetaxel 10 mg/ml - concentrate for infusion - 20 mg/2ml - active: docetaxel 10 mg/ml excipient: citric acid ethanol nitrogen polysorbate 80 - metastatic breast cancer docetaxel sandoz is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. docetaxel sandoz in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.